T1	Participants 79 120	men receiving therapy for prostate cancer
T2	Participants 611 671	men receiving androgen deprivation for their prostate cancer
T3	Participants 1208 1342	195 men (65 subjects per arm) undergoing treatment for prostate cancer involving ADT in the cities of Perth and Brisbane in Australia.
T4	Participants 2630 2671	men receiving therapy for prostate cancer
